Transcenta Holding Limited announced that, as set out above, Dr. Zhao has tendered his resignation as chairman of the Board and non-executive Director of the Company with effect from June 7, 2024 due to his desire to devote more time to his other personal commitments. Dr. Zhao has confirmed that (i) he has no claim against the Company and there is no disagreement between him and the Board; and (ii) there are no matters that need to be brought to the attention of the Stock Exchange and the shareholders of the Company. CHANGE OF CHAIRMAN OF THE BOARD: The Board further announced that, upon the resignation of Dr. Zhao, Dr. Xueming Qian, the executive Director and chief executive officer of the Company, has been appointed as the chairman of the Board with effect from June 7, 2024.

The biographical details of Dr. Qian are set out in the annual report of the Company for the year ended December 31, 2023 published on April 18, 2024. As at the date of this announcement, Dr. Qian is interested in 36,561,000 shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the laws of Hong Kong) of the laws of Hong Kong). CHANGE IN COMPOSITION OF BOARD COMMITTEES Dr. Zhao also ceased to be a member of the audit committee of the Board with effect from June 7, 2024.